Search

Professor Nagy A Habib

General surgery

 

  • Not Fee assured
Overview

Specialises in

  • Hepatobiliary

About me

Nagy Habib is a leading translational researcher on liver cancer and its treatment. He pioneered the first clinical trial in the use of adenovirus and plasmid for the treatment of liver cancer, as well as the use of plasmid gene therapy in hydrodynamic gene delivery. He is the first person in the West to publish a clinical trial on the use of adult bone marrow derived stem cells for the treatment of patients with liver insufficiency.

He has published on the evolution of molecular biology of tumors from oncogene, tumor suppressor gene, epigenetic modification, genetherapy, stem cell therapy, RNA (Ribonucleic acid) and saRNA (small activating RNA) and RNA aptamers.

He is the inventor of, and was co-author of the first publication about the use for radiofrequency in devices used in liver surgery (Habib 4X), as well as interventional endoscopy (Habib EndoHPB – HPB: Hepatopancreatobiliary) and interventional radiology (Habib Percutaneous HPB, Habib VesCoag, Habib VesOpen).

Areas of interest

Liver and pancreatic cancer;
Stem cell therapy;
Gene therapy;
RNA therapy

Medical secretaries

Anaesthetists worked with

About me
My qualifications & training
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • J0200

    Partial hepatectomy (left hepatectomy or resection of up to three segments) +/- cholecystectomy - (1-5)

    Hammersmith Hospital (1-5)

  • J0310

    Resection of liver tumour(s) - (1-5)

    Hammersmith Hospital (1-5)

Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and these third parties declare it to be correct and compliant with their relevant regulatory bodies' standards and codes of conduct. We're unable to guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use here.